Juniperus sabina (Juniperus sabina): Benefits, Dosage, Safety & Evidence

Frequently asked questions

How does Juniperus sabina work as an abortifacient?

Juniperus sabina contains sabinol, thujone, and podophyllotoxin, which act as uterine stimulants that can induce contractions. These compounds disrupt cellular function and are highly toxic to human tissues. The plant was historically used to induce abortion, but this mechanism is directly linked to its severe toxicity profile. Evidence Level C (historical documentation). This herb should never be used therapeutically due to its potential to cause kidney damage, liver failure, and death.

Does Juniperus sabina interact with any medications?

Juniperus sabina should not be combined with any medications as it is highly toxic. Its compounds, particularly thujone and podophyllotoxin, cause significant kidney and liver damage, which could dangerously amplify the effects of drugs metabolized through these organs. Combining this toxic plant with other uterine stimulants, nephrotoxic drugs, or hepatotoxic substances could result in fatal outcomes. There is no safe therapeutic use for this plant.

What is a safe dosage of Juniperus sabina?

There is no safe therapeutic dosage for Juniperus sabina. This plant is classified as highly toxic, with even small amounts capable of causing severe kidney damage, liver toxicity, and potentially death. Historical texts reference its use, but modern herbal medicine strongly advises against any internal or external use. The risk-to-benefit ratio is entirely unfavorable. Evidence Level C confirms historical documentation of toxicity rather than therapeutic benefit.

Is Juniperus sabina safe during pregnancy?

Juniperus sabina is absolutely contraindicated during pregnancy. Historically, it was used specifically as an abortifacient to terminate pregnancies. The active compounds sabinol, thujone, and podophyllotoxin stimulate uterine contractions and can cause miscarriage. Beyond pregnancy termination risks, the plant is highly toxic and can cause maternal kidney damage, liver failure, and death. There is no circumstance where this herb is safe for pregnant individuals.

What are the dangers and side effects of Juniperus sabina?

Juniperus sabina is extremely dangerous with well-documented toxicity. Side effects include severe kidney damage, liver toxicity, and death. The plant contains thujone and podophyllotoxin, which are toxic to multiple organ systems. Even topical application poses risks due to systemic absorption. Historical records document fatalities from both internal and external use. Evidence Level C (historical toxicology reports). This herb is not used in modern herbal practice and should be avoided entirely.

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 30 PubMed articles · model: gemma4:31b

Summary

Juniperus sabina L. is a shrub distributed across Southern Europe, Central Asia, China, and Mongolia, utilized in traditional medicine for various inflammatory and systemic conditions [PMID:39769965, PMID:36426016].

Background

Juniperus sabina L. is a species within the Juniperus genus (section Sabina) that is broadly distributed across Southern Europe and Central Asia [PMID:39769965, PMID:36426016]. It is an important shrub for ecosystem maintenance in mountainous regions and is used for desertification control in arid and semi-arid areas [PMID:36426016, PMID:33756015].

Traditional uses

In Uyghur medicine in China, the berries, branches, and leaves are traditionally used to treat rheumatoid arthritis, itchy skin, tinnitus, deafness, and urinary discomfort [PMID:39769965]. It is also used in the traditional Chinese medicine (TCM) system to prevent or treat various diseases [PMID:37731973].

Active compounds

The plant contains a rich chemical profile of 279 distinct compounds, primarily terpenoids, lignans, flavonoids, and coumarins [PMID:39769965]. Specific bioactive constituents include podophyllotoxin and deoxypodophyllotoxin in the needles [PMID:36142118], and the bioflavonoid cupressuflavone [PMID:38204594, PMID:36771021]. Essential oils contain components such as alpha-pinene, sabinene, and sylvestrene [PMID:37894884].

Mechanism of action

Total flavonoids from J. sabina have been shown to suppress the overproduction of tumor necrosis factor alpha and interleukin 1beta in serum [PMID:27601846]. Cupressuflavone is reported to target inflammation and oxidative stress for neuroprotection [PMID:38204594].

Clinical evidence

Evidence DRheumatoid Arthritis / Inflammation

Total flavonoids from J. sabina significantly inhibited xylene-induced ear edema and ameliorated paw swelling and arthritic scores in rat models [PMID:30069226, PMID:27601846].

Evidence DHepatotoxicity

Essential oil of J. sabina demonstrated a protective effect against CCl4 induced toxicity in male Wistar rats [PMID:31997901].

Evidence DDiabetes

Leaf and fruit extracts showed inhibitory activity on alpha-glucosidase and alpha-amylase enzymes and demonstrated antidiabetic activity in streptozotocin-induced diabetic rats [PMID:29844777].

Evidence DIschemic Brain Injury

Cupressuflavone (CUP) administered to rats reduced brain ischemia/reperfusion damage [PMID:38204594].

Evidence DCardiac Arrhythmia

Ethanolic extracts of J. sabina provided protection against barium chloride-induced arrhythmia in a mouse model [PMID:39204108].

Evidence DCancer

Safety & adverse effects

The plant is noted to have toxicity and limitations [PMID:39769965]. Essential oils exhibit significant allelopathic effects and can inhibit cell division in model plant species [PMID:42171821].

Evidence summary

The current evidence consists primarily of in vitro studies and animal models (Level D), focusing on phytochemical analysis and pharmacological activities such as anti-inflammatory, antidiabetic, and neuroprotective effects. There are no human clinical trials provided in the source abstracts.

PubMed sources

1.PMID: 39769965 (2024) — Phytochemistry, Pharmacology, and Traditional Medicine Applications of Juniperus sabina L.: A Comprehensive Overview. · Molecules (Basel, Switzerland)
2.PMID: 33756015 (2021) — Leaf morphology, photosynthesis and pigments change with age and light regime in savin juniper. · Plant biology (Stuttgart, Germany)
3.PMID: 36142118 (2022) — Juniperus sabina L. as a Source of Podophyllotoxins: Extraction Optimization and Anticholinesterase Activities. · International journal of molecular sciences
4.PMID: 36426016 (2022) — The complete chloroplast genome sequencing data of Juniperus sabina L. (Cupressaceae Bartl.) from Kazakhstan. · Data in brief
5.PMID: 37731973 (2023) — Effects of age and tissue of Juniperus sabina L. on its phytochemical characteristics, anti-cholinesterase, antidiabetes, and anti-drug resistant bacteria activities.

Juniperus sabina

Sources & Citations

Calculate a safe dose of Juniperus sabina